Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

Neurology

Volumn 77, Issue 22, 2011, Pages 1977-1985

  Chen, Y ^a,c   Wolk, D A ^a,b   Reddin, J S ^a   Korczykowski, M ^a   Martinez, P M ^b   Musiek, E S ^a   Newberg, A B ^a   Julin, P ^a   Arnold, S E ^a,b   Greenberg, J H ^a   Detre, John A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; ANGULAR GYRUS; ARTERIAL SPIN LABELING; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; MALE; MINI MENTAL STATE EXAMINATION; NERVE CELL NETWORK; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL;

EID: 82955243781     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823a0ef7     Document Type: Article

References (39)

1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
2. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008;131:665-680. (Pubitemid 351294719)
3. Jagust WJ, Landau SM, Shaw LM, et al. Relationships between biomarkers in aging and dementia. Neurology 2009;73:1193-1199.
4. Jack CR, Jr., Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
5. Jack CR, Jr., Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 2009;132:1355-1365.
6. Vemuri P, Wiste HJ, Weigand SD, et al. MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology 2009;73:294-301.
7. Landau SM, Harvey D, Madison CM, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 2011;32:1207-1218.
8. Schwartz WJ, Smith CB, Davidsen L, et al. Metabolic mapping of functional activity in the hypothalamoneurohypophysial system of the rat. Science 1979;205: 723-725. (Pubitemid 9253867)
9. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001;21:1133-1145. (Pubitemid 32947479)
10. Landau SM, Harvey D, Madison CM, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010;75:230-238.
11. Jueptner M, Weiller C. Review: Does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage 1995;2:148-156.
12. Chen Y, Wang DJ, Detre JA. Test-retest reliability of arterial spin labeling with common labeling strategies. J Magn Reson Imaging 2011;33:940-949.
13. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: Its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 2010;20: 871-880.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:285-297.
15. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006;20:210-216. (Pubitemid 44900933)
16. Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentionalexecutive network function in Alzheimer's disease. Proc Natl Acad Sci USA 2010;107:10256-10261.
17. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-1497.
18. Newberg AB, Wang J, Rao H, et al. Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI-PET scanning. Neuroimage 2005;28:500-506. (Pubitemid 41443519)
19. Jagust WJ, Bandy D, Chen K, et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 2010;6:221-229.
20. Chang L-T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-643.
21. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21-36. (Pubitemid 32552740)
22. Wang Z, Aguirre GK, Rao H, et al. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 2008;26:261-269.
23. Wang J, Alsop DC, Song HK, et al. Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003;50:599-607. (Pubitemid 37082085)
24. Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006;67:1215-1220. (Pubitemid 44563830)
25. Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996;313:106. (Pubitemid 26257767)
26. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289. (Pubitemid 34852226)
27. Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 2008;42:1267-1274.
28. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and Alzheimer disease: Patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856-866.
29. Fleisher AS, Podraza KM, Bangen KJ, et al. Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging 2009;30:1737-1748.
30. Chetelat G, Desgranges B, Landeau B, et al. Direct voxelbased comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008;131: 60-71.
31. Matsuda H, Kitayama N, Ohnishi T, et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 2002;43:304-311. (Pubitemid 34208090)
32. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-194.
33. Villain N, Desgranges B, Viader F, et al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci 2008;28:6174-6181.
34. Alavi A, Newberg AB, Souder E, Berlin JA. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993;34:1681-1687. (Pubitemid 23295377)
35. Petersen ET, Mouridsen K, Golay X. The QUASAR reproducibility study, part II: Results from a multi-center arterial spin labeling test-retest study. Neuroimage 2010;49: 104-113.
36. Xu G, Rowley HA, Wu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease.NMRBiomed 2010;23:286-293.
37. Camargo EE, Szabo Z, Links JM, Sostre S, Dannals RF, Wagner HN, Jr. The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 1992;12:281-290.
38. Amici S, Ogar J, Brambati SM, et al. Performance in specific language tasks correlates with regional volume changes in progressive aphasia. Cogn Behav Neurol 2007; 20:203-211. (Pubitemid 350307876)
39. Venkatraman VK, Aizenstein H, Guralnik J, et al. Executive control function, brain activation and white matter hyperintensities in older adults. Neuroimage 2010;49: 3436-3442.